Human Genome Sciences Inc Quick Ratio (HGSI) starting from the second quarter 2012 to second quarter 2011, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Human Genome Sciences Inc  (HGSI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Human Genome Sciences Inc's Quick Ratio

HGSI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2012, Quick Ratio fell to 1.59 a new company low.

Within Medical Laboratories industry 12 other companies have achieved higher Quick Ratio than Human Genome Sciences Inc in second quarter 2012. While Quick Ratio total ranking in the second quarter 2012 has deteriorated compared to the prior quarter from to 1049.

Explain Quick Ratio?
How much Cash & cash equivalents HGSI´s has?
What are HGSI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HGSI Quick Ratio (Jun 30 2012)
Q2		 (Mar 31 2012)
Q1		 (Dec 31 2011)
Q4		 (Sep 30 2011)
Q3		 (Jun 30 2011)
Q2
Y / Y Current Liabilities Change 12.04 % 5.42 % 8.46 % - -
Y / Y Cash & cash equivalent Change -33.15 % 168.28 % -5.57 % - -
Quick Ratio MRQ 1.59 2.9 2.75 1.77 2.67
HGSI's Total Ranking # 1049 # # # #
Seq. Current Liabilities Change 6.88 % -13.86 % -8.49 % 32.98 % 0.56 %
Seq. Cash & cash equivalent Change -41.13 % -9.39 % 42.23 % -11.89 % 136.25 %



Quick Ratio second quarter 2012 Company Ranking
Within: No.
Medical Laboratories Industry # 13
Healthcare Sector # 276
Overall Market # 1049


Quick Ratio Statistics
High Average Low
1.59 1.59 1.59
(Jun 30 2012)  




Financial Statements
Human Genome Sciences Inc's Current Liabilities $ 295 Millions Visit HGSI's Balance sheet
Human Genome Sciences Inc's Cash & cash equivalent $ 470 Millions Visit HGSI's Balance sheet
Source of HGSI's Sales Visit HGSI's Sales by Geography


Cumulative Human Genome Sciences Inc's Quick Ratio

HGSI's Quick Ratio for the trailling 12 Months

HGSI Quick Ratio

 (Jun 30 2012)
12 Months		 (Mar 31 2012)
12 Months		 (Dec 31 2011)
12 Months		 (Sep 30 2011)
12 Months		 (Jun 30 2011)
12 Months
Y / Y Current Liabilities TTM Growth 51.31 % 117.11 % 304.74 % - -
Y / Y Cash & cash equivalent TTM Growth 43.2 % 143.94 % 168.08 % - -
Quick Ratio TTM 2.23 2.48 2.09 2.18 2.36
Total Ranking TTM # 1153 # 594 # 732 # #
Seq. Current Liabilities TTM Growth 2.62 % 1.19 % 2.14 % 42.67 % 47.25 %
Seq. Cash & cash equivalent TTM Growth -7.76 % 20.02 % -2.03 % 32.04 % 57.13 %

Quick ratio ranking by company, industry and sector >> Back to HGSI Financial Strength Comparisons >> Go to Compare HGSI Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2012 to $294.82 millions, cumulative Quick Ratio decreased to 2.23 above the HGSI average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 22 other companies have achieved higher Quick Ratio than Human Genome Sciences Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2012 from to 2907.

Explain Quick Ratio?
How much Cash & cash equivalents HGSI´s has?
What are HGSI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 23
Healthcare Sector # 441
Within the Market # 1049


trailing twelve months Quick Ratio Statistics
High Average Low
0.84 0.64 0.42
(Jun 30 2012)   (Dec 31 2011)




Companies with similar Quick Ratio in the quarter ending Jun 30 2012, within Medical Laboratories Industry Quick RatioJun 30 2012 MRQ Cash & cash equivalentJun 30 2012 MRQ Current Liabilities
Nuo Therapeutics, Inc.  2.69 $ 8.598  Millions$ 3.193  Millions
Psychemedics Corporation  2.14 $ 4.762  Millions$ 2.229  Millions
Incyte Corporation  1.94 $ 271.306  Millions$ 139.731  Millions
Dyax Corp  1.79 $ 38.585  Millions$ 21.566  Millions
Hologic Inc  1.63 $ 905.606  Millions$ 557.107  Millions
Human Genome Sciences Inc  1.59 $ 470.167  Millions$ 294.820  Millions
Complete Genomics Inc  0.99 $ 43.258  Millions$ 43.690  Millions
Luna Innovations Inc  0.93 $ 6.640  Millions$ 7.120  Millions
American Shared Hospital Services  0.89 $ 9.050  Millions$ 10.130  Millions
Icon Plc  0.80 $ 168.038  Millions$ 210.684  Millions
Biocept Inc   0.62 $ 13.087  Millions$ 21.026  Millions
Nrc Health  0.44 $ 11.168  Millions$ 25.272  Millions
Aeon Global Health Corp.  0.38 $ 2.502  Millions$ 6.513  Millions

Date modified: 2026-09-08T15:07:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.